Sign in

    Petmed Express Inc (PETS)

    You might also like

    PetMed Express, Inc. (d/b/a PetMeds) is a leading nationwide direct-to-consumer pet pharmacy that provides a variety of products and services for pets, including prescription and non-prescription medications, food, supplements, supplies, and veterinary services. The company primarily caters to pet owners of dogs, cats, and horses, offering convenience, competitive pricing, fast delivery, and high-quality customer service. PetMeds markets its products through its websites, toll-free numbers, and mobile applications, making it a prominent player in the growing pet care industry.

    1. Non-Prescription Medications (OTC) and Supplies - Offers flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and other pet supplies.
    2. Prescription Medications (Rx) - Provides heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure treatments, and other specialty medications, including generic substitutes.
    3. Pet Foods - Sells premium pet foods, including veterinary prescription diets tailored to specific health needs.
    4. Other Products and Services - Includes telemedicine services through VetLive, enabling consultations, diagnoses, and prescriptions by board-certified veterinarians, as well as pet insurance offerings.
    NamePositionExternal RolesShort Bio

    Sandra Y. Campos

    ExecutiveBoard

    CEO and President

    Board Member at Big Lots (NYSE: BIG), Fabric, PureRED; Operating Advisor at ShoulderUp Technology Acquisition Corp

    Sandra Y. Campos joined PETS as CEO and President on April 29, 2024. She has extensive experience in e-commerce, retail, and brand management, previously serving as CEO of Diane von Furstenberg and Co-President of Women’s Apparel at Global Brands Group. She also focuses on unlocking shareholder value and integrating teams for growth.

    View Report →

    Christine Chambers

    Executive

    CFO, Treasurer, and Secretary

    None

    Christine Chambers has been CFO since August 2022, Treasurer since October 2022, and Secretary since May 2023. She has a strong financial background, having previously served as CFO at RealNetworks and held leadership roles at Rosetta Stone and the Bill & Melinda Gates Foundation.

    Doug Krulik

    Executive

    Chief Accounting Officer

    None

    Doug Krulik became the Chief Accounting Officer of PETS on August 19, 2024. He has extensive experience in accounting and finance, having held leadership roles at Etherio Holdings, Jushi Holdings, and Magic Leap. He is a Certified Public Accountant (CPA) and holds an MBA from the University of Miami.

    Robyn D’Elia

    Executive

    CFO

    Board Member and Audit Committee Chair at itel

    Robyn D’Elia joined PETS as CFO on September 16, 2024. She previously served as CFO at Odeko and Bed Bath & Beyond, where she oversaw significant revenue growth. She also founded RMD Advisory and advised on major transactions, including the sale of Aerie Pharmaceuticals.

    Diana Garvis Purcel

    Board

    Director

    Board Member at Ocean Power Technologies (NYSE: OPTT)

    Diana Garvis Purcel joined the PETS Board in April 2022 and serves as Chair of the Audit Committee. She is recognized as an "audit committee financial expert" and brings significant financial expertise to the company. She also serves on the board of Ocean Power Technologies.

    Gian M. Fulgoni

    Board

    Director

    Board Member at Prophet, Fluree, Varcode, QualSights, HealthBridge; Senior Advisory Board Member for the Journal of Advertising Research; Venture Partner at 4490 Ventures

    Gian M. Fulgoni has been a PETS Director since November 2002. He is a co-founder of comScore, Inc., and has extensive experience in marketing, advertising, and strategic decision-making. He serves on multiple boards and advisory roles, leveraging his expertise to guide PETS in evaluating marketing opportunities and addressing strategic challenges.

    Justin Mennen

    Board

    Director

    Advisory Board Member at University of Kansas Business School; Governing Body Co-Chair at Global CIO Executive Summit of Evanta

    Justin Mennen joined the PETS Board on June 3, 2024. He has over two decades of experience in digital technology transformation and previously held executive roles at Rite Aid Corporation, CompuCom Systems, and Estée Lauder Companies. He also serves in advisory roles at the University of Kansas and Evanta.

    Leah Solivan

    Board

    Director

    Managing Director at Fuel Capital; Advisor to Monica + Andy; Venture Advisor to Screendoor Partners; Leadership roles in Young Presidents’ Organization (YPO)

    Leah Solivan joined the PETS Board on June 24, 2024. She is the founder of TaskRabbit, which she scaled into an international business before its acquisition by IKEA. She is also a Managing Director at Fuel Capital and holds advisory and leadership roles in various organizations, including YPO.

    Leslie C.G. Campbell

    Board

    Chair of the Board

    Board Member at Shapeways (NYSE: SHPW), PointClickCare, Riley Inc., Diligent, Bideawee Inc.; Advisory Board Member at Grapevine Solutions; Growth Advisory Board Member at Diligent

    Leslie C.G. Campbell has been on the PETS Board since July 2018 and became Chair on January 5, 2024. She is recognized for her expertise in corporate governance, technology, and supply chain management. She also serves on multiple boards and advisory committees, contributing to her extensive leadership experience.

    1. You have experienced three consecutive quarters of double-digit revenue declines ; besides pulling back on marketing spend, what are the other factors contributing to this softness, and how do you plan to reverse this trend?
    2. With reduced visits to veterinarians and pressure on customer spending , how are you adjusting your strategy to address reduced prescriptions and maintain customer compliance in your pharmacy segment?
    3. Given that you've eliminated 4,000 underperforming SKUs, which you say did not impact revenues , how do you ensure that SKU rationalization doesn't limit your ability to attract new customers and meet their product needs?
    4. Despite having a strong cash position of $50 million , why aren't you investing more heavily in marketing and promotions to drive revenue growth and new customer acquisition, especially in a competitive market?
    5. As you modernize your website and marketing to attract younger consumers but acknowledge that this will take time and multiple touchpoints , how do you plan to bridge the revenue gap and maintain growth during this transition period?
    Program DetailsProgram 1
    Approval DateN/A
    End Date/DurationN/A
    Total Additional AmountN/A
    Remaining Authorization$28.7 million as of 2023-03-31
    DetailsThe program allows repurchases in the open market or private transactions, subject to market conditions. Shares may be canceled or held in treasury. No shares were repurchased during fiscal 2023 or 2022.

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    PetCareRx, Inc.

    2024

    PetMed Express acquired PetCareRx through a cash-funded merger for $36.1 million (with $26.7 million in goodwill) to become its wholly-owned subsidiary, expanding its product catalog (especially non‐medication products), distribution capabilities, and customer base by adding about 286,000 customers along with key intangible assets and a strong membership program.

    No recent press releases or 8-K filings found for PETS.